Agentix Corp. (AGTX) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
32932 PACIFIC COAST HIGHWAY DANA POINT, CA 92629 |
| State of Incorp. | NV |
| Fiscal Year End | March 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2024 Q3 | 9/30/2024 Q2 | 6/30/2024 Q1 | 3/31/2024 Q4 | 12/31/2023 Q3 | 9/30/2023 Q2 | 6/30/2023 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Prepaid expense | 164 | 158 | 104 | 291 | 298 | ||||
| Other undisclosed current assets | 6 | 9 | 106 | 8 | 43 | 32 | |||
| Total current assets: | 170 | 167 | 106 | 112 | 334 | 331 | |||
| Noncurrent Assets | |||||||||
| TOTAL ASSETS: | 170 | 167 | 106 | 112 | 334 | 331 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,166 | 1,105 | 985 | 1,129 | 1,448 | 1,341 | |||
| Accounts payable | 1,128 | 1,070 | 962 | 1,106 | 1,439 | 1,327 | |||
| Accrued liabilities | 38 | 35 | 24 | 22 | 9 | 14 | |||
| Other undisclosed current liabilities | 1,841 | 1,788 | 1,681 | 1,829 | 1,701 | 1,642 | |||
| Total current liabilities: | 3,007 | 2,893 | 2,667 | 2,958 | 3,149 | 2,983 | |||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 3,007 | 2,893 | 2,667 | 2,958 | 3,149 | 2,983 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (2,837) | (2,726) | (2,560) | (2,846) | (2,815) | (2,652) | |||
| Preferred stock | 40 | ||||||||
| Common stock | 54 | 40 | 40 | 40 | 40 | 40 | |||
| Common stock, value, subscriptions | 54 | 54 | 54 | 54 | |||||
| Additional paid in capital | 3,288 | 3,288 | 3,288 | 3,026 | 3,026 | 3,026 | |||
| Accumulated other comprehensive income (loss) | (23) | 12 | |||||||
| Accumulated deficit | (6,196) | (6,105) | (5,954) | (5,951) | (5,958) | (5,779) | |||
| Other undisclosed equity, attributable to parent | (3) | 54 | (14) | 23 | 7 | ||||
| Total equity: | (2,837) | (2,726) | (2,560) | (2,846) | (2,815) | (2,652) | |||
| TOTAL LIABILITIES AND EQUITY: | 170 | 167 | 106 | 112 | 334 | 331 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 12/31/2024 Q3 | 9/30/2024 Q2 | 6/30/2024 Q1 | 3/31/2024 Q4 | 12/31/2023 Q3 | 9/30/2023 Q2 | 6/30/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 198 | 198 | ||||||
| Other income | 198 | |||||||
| Gross profit: | 198 | |||||||
| Operating expenses | (93) | (151) | 198 | (16) | (353) | (401) | ||
| Other undisclosed operating loss | (198) | |||||||
| Operating income (loss): | (93) | (151) | 198 | (16) | (353) | (401) | ||
| Nonoperating income (expense) | 2 | 1 | (22) | (174) | (3) | |||
| Loss, foreign currency transaction, before tax | (3) | |||||||
| Other nonoperating income (expense) | 2 | 1 | (22) | (174) | ||||
| Interest and debt expense | (3) | (6) | (5) | |||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (160) | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (91) | (151) | 38 | (41) | (533) | (410) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 319 | |||||||
| Income (loss) from continuing operations: | (91) | (151) | 357 | (41) | (533) | (410) | ||
| Other undisclosed net loss | (1,885) | |||||||
| Net loss: | (91) | (151) | (1,528) | (41) | (533) | (410) | ||
| Other undisclosed net income attributable to parent | 1,885 | 48 | 354 | 6 | ||||
| Net income (loss) available to common stockholders, diluted: | (91) | (151) | 357 | 6 | (179) | (403) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2024 Q3 | 9/30/2024 Q2 | 6/30/2024 Q1 | 3/31/2024 Q4 | 12/31/2023 Q3 | 9/30/2023 Q2 | 6/30/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (91) | (151) | (1,528) | (41) | (533) | (410) | ||
| Other comprehensive loss | (31) | (163) | (403) | |||||
| Other undisclosed comprehensive loss | (945) | |||||||
| Comprehensive loss: | (91) | (151) | (2,473) | (72) | (696) | (813) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (20) | (15) | 12 | |||||
| Comprehensive loss, net of tax, attributable to parent: | (111) | (166) | (2,461) | (72) | (696) | (813) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.